Optimal Control of the COVID-19 Pandemic with Non-pharmaceutical Interventions

The COVID-19 pandemic has forced societies across the world to resort to social distancing to slow the spread of the SARS-CoV-2 virus. Due to the economic impacts of social distancing, there is growing desire to relax these measures. To characterize a range of possible strategies for control and to understand their consequences, we performed an optimal control analysis of a mathematical model of SARS-CoV-2 transmission. Given that the pandemic is already underway and controls have already been initiated, we calibrated our model to data from the US and focused our analysis on optimal controls from May 2020 through December 2021. We found that a major factor that differentiates strategies that prioritize lives saved versus reduced time under control is how quickly control is relaxed once social distancing restrictions expire in May 2020. Strategies that maintain control at a high level until summer 2020 allow for tapering of control thereafter and minimal deaths, whereas strategies that relax control in the short term lead to fewer options for control later and a higher likelihood of exceeding hospital capacity. Our results also highlight that the potential scope for controlling COVID-19 until a vaccine is available depends on epidemiological parameters about which there is still considerable uncertainty, including the basic reproduction number and the effectiveness of social distancing. In light of those uncertainties, our results do not constitute a quantitative forecast and instead provide a qualitative portrayal of possible outcomes from alternative approaches to control.

[1]  Centers for Disease Control and Prevention CDC COVID-19 Response Team Severe Outcomes Among Patients with Coronavirus Disease 2019 (COVID-19) — United States, February 12–March 16, 2020 , 2020, MMWR. Morbidity and mortality weekly report.

[2]  M. Keeling,et al.  Modeling Infectious Diseases in Humans and Animals , 2007 .

[3]  Carl A. B. Pearson,et al.  The effect of control strategies to reduce social mixing on outcomes of the COVID-19 epidemic in Wuhan, China: a modelling study , 2020, The Lancet Public Health.

[4]  Nuno R. Faria,et al.  The effect of human mobility and control measures on the COVID-19 epidemic in China , 2020, Science.

[5]  J. Martin,et al.  Births: Final Data for 2018. , 2019, National vital statistics reports : from the Centers for Disease Control and Prevention, National Center for Health Statistics, National Vital Statistics System.

[6]  M. T. Sofonea,et al.  Optimal COVID-19 epidemic control until vaccine deployment , 2020, medRxiv.

[7]  Eunok Jung,et al.  Optimal Tuberculosis Prevention and Control Strategy from a Mathematical Model Based on Real Data , 2014, Bulletin of mathematical biology.

[8]  Yonatan H. Grad,et al.  Projecting the transmission dynamics of SARS-CoV-2 through the postpandemic period , 2020, Science.

[9]  C. Murray Forecasting COVID-19 impact on hospital bed-days, ICU-days, ventilator-days and deaths by US state in the next 4 months , 2020, medRxiv.

[10]  Matt J Keeling,et al.  Estimation of country-level basic reproductive ratios for novel Coronavirus (COVID-19) using synthetic contact matrices , 2020, medRxiv.

[11]  M. Lipsitch,et al.  Projecting the transmission dynamics of SARS-CoV-2 through the postpandemic period , 2020, Science.

[12]  Julia E. Aledort,et al.  Non-pharmaceutical public health interventions for pandemic influenza: an evaluation of the evidence base , 2007, BMC public health.

[13]  S. Lindstrom,et al.  First Case of 2019 Novel Coronavirus in the United States , 2020, The New England journal of medicine.

[14]  Karline Soetaert,et al.  Solving Differential Equations in R: Package deSolve , 2010 .

[15]  M. Kraemer,et al.  Preparedness and vulnerability of African countries against importations of COVID-19: a modelling study , 2020, The Lancet.

[16]  Suzanne Lenhart,et al.  Backward Bifurcation and Optimal Control in Transmission Dynamics of West Nile Virus , 2010, Bulletin of mathematical biology.

[17]  Nita H. Shah,et al.  Control Strategies to Curtail Transmission of COVID-19 , 2020, medRxiv.

[18]  Eunha Shim,et al.  Optimal strategies of social distancing and vaccination against seasonal influenza. , 2013, Mathematical biosciences and engineering : MBE.

[19]  Peng Wu,et al.  Impact assessment of non-pharmaceutical interventions against coronavirus disease 2019 and influenza in Hong Kong: an observational study , 2020, The Lancet Public Health.

[20]  M. Postma,et al.  An optimal control theory approach to non-pharmaceutical interventions , 2010, BMC infectious diseases.

[21]  Tamara Pilishvili,et al.  Geographic Differences in COVID-19 Cases, Deaths, and Incidence — United States, February 12–April 7, 2020 , 2020, MMWR. Morbidity and mortality weekly report.

[22]  C. Whittaker,et al.  Report 9: Impact of non-pharmaceutical interventions (NPIs) to reduce COVID19 mortality and healthcare demand , 2020 .

[23]  Joshua B. Plotkin,et al.  Optimal, near-optimal, and robust epidemic control , 2020, Communications Physics.

[24]  G. Chowell,et al.  Estimating the asymptomatic proportion of coronavirus disease 2019 (COVID-19) cases on board the Diamond Princess cruise ship, Yokohama, Japan, 2020 , 2020, Euro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin.

[25]  A. Schuchat,et al.  COVID-19: towards controlling of a pandemic , 2020, The Lancet.

[26]  Facundo Piguillem,et al.  Optimal Covid-19 Quarantine and Testing Policies , 2020, The Economic Journal.

[27]  Oscar Patterson-Lomba,et al.  Optimal timing for social distancing during an epidemic , 2020, medRxiv.

[28]  A. Tse,et al.  New York Times Coronavirus (Covid-19) Data in the United States , 2020 .

[29]  The Lancet COVID-19 in the USA: a question of time , 2020, The Lancet.

[30]  Chandini Raina MacIntyre,et al.  Mathematical assessment of the impact of non-pharmaceutical interventions on curtailing the 2019 novel Coronavirus , 2020, Mathematical Biosciences.

[31]  A. Tatem,et al.  Effect of non-pharmaceutical interventions for containing the COVID-19 outbreak in China , 2020, medRxiv.

[32]  John T. Workman,et al.  Optimal Control Applied to Biological Models , 2007 .

[33]  S. Lenhart,et al.  Modeling Optimal Intervention Strategies for Cholera , 2010, Bulletin of mathematical biology.

[34]  Quentin J. Leclerc,et al.  Quantifying the impact of physical distance measures on the transmission of COVID-19 in the UK , 2020, BMC Medicine.

[35]  Wei Aun Yap,et al.  Time-variant strategies for optimizing the performance of non-pharmaceutical interventions (NPIs) in protecting lives and livelihoods during the COVID-19 pandemic , 2020, medRxiv.

[36]  G. Onder,et al.  Case-Fatality Rate and Characteristics of Patients Dying in Relation to COVID-19 in Italy. , 2020, JAMA.

[37]  Anita Lerch,et al.  Estimating unobserved SARS-CoV-2 infections in the United States , 2020, Proceedings of the National Academy of Sciences.

[38]  James Watmough,et al.  Further Notes on the Basic Reproduction Number , 2008 .

[39]  S. Bhatt,et al.  Report 13: Estimating the number of infections and the impact of non-pharmaceutical interventions on COVID-19 in 11 European countries , 2020 .

[40]  Jessica T Davis,et al.  The effect of travel restrictions on the spread of the 2019 novel coronavirus (COVID-19) outbreak , 2020, Science.

[41]  Michael Li,et al.  Reconciling early-outbreak estimates of the basic reproductive number and its uncertainty: framework and applications to the novel coronavirus (SARS-CoV-2) outbreak , 2020, Journal of the Royal Society Interface.

[42]  S. C. Mpeshe,et al.  Optimal Control and Sensitivity Analysis of an Influenza Model with Treatment and Vaccination , 2011, Acta biotheoretica.

[43]  David N. Fisman,et al.  Mathematical modelling of COVID-19 transmission and mitigation strategies in the population of Ontario, Canada , 2020, Canadian Medical Association Journal.

[44]  F. Agusto,et al.  Optimal control strategies for dengue transmission in pakistan. , 2018, Mathematical biosciences.

[45]  N. Lurie,et al.  Developing Covid-19 Vaccines at Pandemic Speed. , 2020, The New England journal of medicine.

[46]  N. G. Davies,et al.  Effects of non-pharmaceutical interventions on COVID-19 cases, deaths, and demand for hospital services in the UK: a modelling study , 2020, The Lancet Public Health.

[47]  R. Reiner,et al.  Heterogeneous local dynamics revealed by classification analysis of spatially disaggregated time series data , 2018, bioRxiv.

[48]  Abhishek Mallela Optimal Control applied to a SEIR model of 2019-nCoV with social distancing , 2020, medRxiv.

[49]  D. Fisman,et al.  Mathematical modeling of COVID-19 transmission and mitigation strategies in the population of Ontario, Canada , 2020 .